Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 401

    1.

    Vitamin C pharmacokinetics: implications for oral and intravenous use.

    Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, Wesley RA, Levine M.

    Ann Intern Med. 2004 Apr 6;140(7):533-7.PMID: 15068981 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate.

    Duconge J, Miranda-Massari JR, Gonzalez MJ, Jackson JA, Warnock W, Riordan NH.

    P R Health Sci J. 2008 Mar;27(1):7-19. Review.PMID: 18450228 [PubMed - indexed for MEDLINE]Related articles

    3.

    Intravenously administered vitamin C as cancer therapy: three cases.

    Padayatty SJ, Riordan HD, Hewitt SM, Katz A, Hoffer LJ, Levine M.

    CMAJ. 2006 Mar 28;174(7):937-42.PMID: 16567755 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.

    Slain D, Amsden JR, Khakoo RA, Fisher MA, Lalka D, Hobbs GR.

    Pharmacotherapy. 2005 Feb;25(2):165-70.PMID: 15767232 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.

    Bergman AJ, Stevens C, Zhou Y, Yi B, Laethem M, De Smet M, Snyder K, Hilliard D, Tanaka W, Zeng W, Tanen M, Wang AQ, Chen L, Winchell G, Davies MJ, Ramael S, Wagner JA, Herman GA.

    Clin Ther. 2006 Jan;28(1):55-72.PMID: 16490580 [PubMed - indexed for MEDLINE]Related articles

    6.

    Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats.

    Egorin MJ, Yuan ZM, Sentz DL, Plaisance K, Eiseman JL.

    Cancer Chemother Pharmacol. 1999;43(6):445-53.PMID: 10321503 [PubMed - indexed for MEDLINE]Related articles

    7.

    Single-dose clinical pharmacokinetic studies of gefitinib.

    Swaisland HC, Smith RP, Laight A, Kerr DJ, Ranson M, Wilder-Smith CH, Duvauchelle T.

    Clin Pharmacokinet. 2005;44(11):1165-77.PMID: 16231967 [PubMed - indexed for MEDLINE]Related articles

    9.

    Pharmacokinetic properties of rosuvastatin after single-dose, oral administration in Chinese volunteers: a randomized, open-label, three-way crossover study.

    Li Y, Jiang X, Lan K, Zhang R, Li X, Jiang Q.

    Clin Ther. 2007 Oct;29(10):2194-203.PMID: 18042475 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.

    Escher M, Daali Y, Chabert J, Hopfgartner G, Dayer P, Desmeules J.

    Clin Ther. 2007 Aug;29(8):1620-31.PMID: 17919544 [PubMed - indexed for MEDLINE]Related articles

    11.

    The pharmacokinetics of linezolid are not affected by concomitant intake of the antioxidant vitamins C and E.

    Gordi T, Tan LH, Hong C, Hopkins NJ, Francom SF, Slatter JG, Antal EJ.

    J Clin Pharmacol. 2003 Oct;43(10):1161-7.PMID: 14517199 [PubMed - indexed for MEDLINE]Related articles

    12.

    Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administration.

    Schilsky RL, Ratain MJ.

    J Natl Cancer Inst. 1990 Sep 5;82(17):1411-5.PMID: 2388292 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pharmacokinetics and tolerability of intramuscular, oral and intravenous aripiprazole in healthy subjects and in patients with schizophrenia.

    Boulton DW, Kollia G, Mallikaarjun S, Komoroski B, Sharma A, Kovalick LJ, Reeves RA.

    Clin Pharmacokinet. 2008;47(7):475-85.PMID: 18563956 [PubMed - indexed for MEDLINE]Related articles

    14.

    Serum ascorbic acid concentrations in previously unsupplemented greyhounds after administration of a single dose of ascorbic acid intravenously or per os.

    Scott KC, Hill RC, Lewis DD, Gronwall R, Sundstrom DA, Jones GL, Harper J.

    J Anim Physiol Anim Nutr (Berl). 2002 Aug;86(7-8):222-8.PMID: 15379908 [PubMed - indexed for MEDLINE]Related articles

    15.

    Pharmacokinetic profile of intramuscular fulvestrant in advanced breast cancer.

    Robertson JF, Erikstein B, Osborne KC, Pippen J, Come SE, Parker LM, Gertler S, Harrison MP, Clarke DA.

    Clin Pharmacokinet. 2004;43(8):529-38.PMID: 15170367 [PubMed - indexed for MEDLINE]Related articles

    16.
    17.

    Clinical pharmacokinetics of 5-aminolevulinic acid in healthy volunteers and patients at high risk for recurrent bladder cancer.

    Dalton JT, Yates CR, Yin D, Straughn A, Marcus SL, Golub AL, Meyer MC.

    J Pharmacol Exp Ther. 2002 May;301(2):507-12.PMID: 11961050 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Supplemental Content

    Find related data